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Population structure has been presumed to cause many of the unreplicated disease-marker associations reported in
the literature, yet few actual case-control studies have been evaluated for the presence of structure. Here, we examine
four moderate case-control samples, comprising 3,472 individuals, to determine if detectable population subdivision
is present. The four population samples include: 500 U.S. whites and 236 African Americans with hypertension;
and 500 U.S. whites and 500 Polish whites with type 2 diabetes, all with matched control subjects. Both diabetes
populations were typed for the PPARg Pro12Ala polymorphism, to replicate this well-supported association (Al-
tshuler et al. 2000). In each of the four samples, we tested for structure, using the sum of the case-control allele
frequency x2 statistics for 9 STR and 35 SNP markers (Pritchard and Rosenberg 1999). We found weak evidence
for population structure in the African American sample only, but further refinement of the sample, to include only
individuals with U.S.-born parents and grandparents, eliminated the stratification. Our examples provide insight
into the factors affecting the replication of association studies and suggest that carefully matched, moderate-sized
case-control samples in cosmopolitan U.S. and European populations are unlikely to contain levels of structure
that would result in significantly inflated numbers of false-positive associations. We explore the role that extreme
differences in power among studies, due to sample size and risk-allele frequency differences, may play in the
replication problem.
Introduction
Association studies for mapping disease-related genes
have gained in popularity over traditional family-based
linkage analyses. In principle, for an equivalent number
of genotypes and for common disease alleles, population-
based tests of association offer far greater power to detect
the presence of genes whose effects (or relative risks) are
minor than do pedigree-based designs in which a greater
fraction of the genome is correlated among closely related
pedigree members (Risch and Merikangas 1996). Nev-
ertheless, population-based studies are regardedwith con-
siderable skepticism, which is frequently vindicated by
apparently false or nonreplicable associations (Editorial
1999;Weiss et al. 2001). A common explanation for these
false associations is that unrecognized population strati-
fication produces spurious associations at loci of which
the allele frequencies differ coincidentally among the sub-
populations comprising the case and control subjects
(Lander and Schork 1994; Risch 2000; Cardon and Bell
2001; Peltonen et al. 2001). Specifically, false-positive as-
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sociations may arise if case and control subjects are drawn
differentially from two or more subpopulations in which
marker allele frequencies and disease prevalence differ
across the subpopulations. For this reason, tremendous
effort has been devoted over the past decade to the de-
velopment of family-based tests of both association and
linkage. The transmission/disequilibrium test (TDT) (Spi-
elman et al. 1993), which uses untransmitted parental
chromosomes as controls, pioneered this approach. Nu-
merous extensions for various family-based designs are
now available. The primary drawbacks of family-based
association designs are that use of closely related controls
reduces power considerably and that recruitment of fam-
ily members is often difficult or impossible, particularly
for late-onset diseases.
To date, the extent of population structure in actual
population-based case-control studies has not been ex-
amined carefully. There is scant evidence that stratifica-
tion is to blame for the perceived excess of false-positive
associations in case-control studies, and theoretical con-
siderations seem to put strict limits on the contribution
that stratification can make (Wacholder et al. 2000). Fur-
thermore, it is not clear that failures to replicate reported
associations are lower for family-based versus popula-
tion-based tests of association (Ioannidis et al. 2001).
Although population stratification has been emphasized
as an explanation for failures to replicate reported as-
sociations, other factors may turn out to be more im-
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portant. Chief among thesemay be the overinterpretation
of marginal findings, inadequate (or too restrictive) cor-
rections for multiple hypothesis testing, publication bi-
ases toward positive results, differing or inadequate clin-
ical diagnostic criteria, inadequate sample sizes, differ-
ences in risk-allele frequency among studies, and genuine
locus or allelic heterogeneity among different population
samples (Gambaro et al. 2000; Cardon and Bell 2001;
Ioannidis et al. 2001; Vieland 2001).
In an effort to recoup some of the statistical power
lost to family-based study designs, a recent trend has
focused on recognizing when structure may affect a
case-control study and correcting for it when it is pre-
sent (Devlin and Roeder 1999; Pritchard and Rosenberg
1999; Pritchard et al. 2000a, 2000b; Reich and Gold-
stein 2001). When case and control samples are drawn
from different subpopulations, allele frequencies will
tend to differ among the subpopulations for most ran-
domly chosen loci. Population subdivision can then be
detected by genotyping a number of unlinked markers
and looking for systematic differences in allele fre-
quency. A single measure of collective difference in allele
frequency can be used to detect an overall deviation
between populations or subpopulations (Pritchard and
Rosenberg 1999). In the event that structure is detected,
two general approaches have been proposed to correct
for it. One method, commonly known as “genomic con-
trol,” uses the observed patterns of variation at unlinked
loci to calculate empirical test statistic distributions for
use in evaluating the validity of an association (Prit-
chard and Rosenberg 1999; Devlin and Roeder 1999;
Reich and Goldstein 2001). A second take on the prob-
lem uses data from random, unlinked markers to iden-
tify cryptic subpopulations (Pritchard et al. 2000b; Sat-
ten et al. 2001; Thornsberry et al. 2001). Tests of assoc-
iation are then essentially performed in each of the iden-
tified subpopulations.
Here, we implement some of these recently proposed
methods to test for the presence of structure in four
independent case-control sample sets, all selected from
the Global Repository at Genomics Collaborative, Inc.
(GCI), as part of ongoing association studies. In two of
these case-control samples, we also test whether we can
detect a well-supported association with the PPARg
Pro12Ala polymorphism and type 2 diabetes (DM2)
(Altshuler et al. 2000), and we examine the possible
impact of structure on the association observed in these
two replicate samples.
Methods
Case-Control Samples
Four separate case-control samples were selected from
samples residing in the Global Repository at GCI. The
repository contains globally collected DNA samples from
1100,000 individuals enrolled in studies of multifactorial
disease, as well as samples from healthy individuals en-
rolled as control subjects. In addition to extensive clinical
data, all samples in the repository have data on self-re-
ported ethnicity for three generations, place and country
of birth with current living place, location and country
of birth for both parents, country of birth for all four
grandparents, and languages spoken in the home. For all
samples, controls were matched individually with cases,
by use of multiple criteria including age ( 5 years), sex
(exact match), BMI ( 2.5 units), and individual and
family disease history. Demographic information used in
matching control subjects varied but included self-re-
ported ethnicity, for each index individual, and, in the
U.S. samples, geographic region of current residence (on
the basis of a four-region breakdown). No birth-country
information was used in matching case subjects to control
subjects. The four study populations were (1) 500 white
case subjects with hypertension and 500 white control
subjects, from theUnited States; (2) 236AfricanAmerican
case subjects with hypertension and 236 African Ameri-
can control subjects; (3) 500 white case subjects with
DM2 and 500 white control subjects, from the United
States; and (4) 500 white case subjects with DM2 and
500white control subjects, fromPoland. All samples from
Poland came from a single location. All U.S. whites were
non-Hispanic. Parents and grandparents of the individ-
uals in the African American sample were also required
to be African American. Clinical information used to de-
fine each case sample varied among the specific studies;
however, the two diabetes patient samples were chosen
specifically as replicates of one another and thus identical
clinical criteria were used. Individuals with BMI 135 kg/
m2 were excluded from both DM2 case samples, and in-
clusion preference was given to individuals with one first-
degree relative who also had DM2. All case individuals
were defined as having at least one fasting blood glucose
measurement 1140 mg/dL at diagnosis.
Genotyping
The PPARg Pro12Ala polymorphism was genotyped in
the two diabetic case-control samples (Poland and U.S.
whites), by use of Sequenom’s Mass Array technology
(Ross et al. 1998). To assess structure, 40 biallelic SNPs
were chosen from a public SNP reference database (SNP
Consortium Web site). Each included SNP was chosen to
have a minor allele frequency of at least 0.2 in the African
American and white population samples reported in the
database. Firm estimates of the level of structure that a
given collection of markers can detect are difficult to ob-
tain with incomplete information on allele frequencies in
the various subpopulations; however, simulations (Prit-
chard and Rosenberg 1999) indicate that 30 biallelic
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markers should have reasonable power to detect strati-
fication in the subpopulations that have diverged only
recently (within the past 10,000 years), such as the main
population groups we compare here. To minimize the
likelihood that any two SNPs were in linkage disequilib-
rium (LD), we chose one SNP per chromosome arm
(where precise mapping information was available), with
the exception of the Y chromosome. Suitable SNPs were
not available at the time of choosing on chromosomes
17, 19, 21, and 22; and only one suitable SNP was found
on chromosome 9. To reach a total of 40 SNPs, 3 each
were chosen on the three largest chromosomes—1, 2, and
3. Genotyping of SNPs was performed by mass spec-
troscopy performed with Qiagen’s Masscode system (Ko-
koris et al. 2000). Additionally, a panel of 10 tetranucle-
otide STR markers (Profiler Plus, Applied Biosystems) are
typed on all DNA samples in the repository as part of
the routine quality-control process. These markers show
large differences in population allele frequency, since the
panel is used for identifying humans. One of the markers
is a sex-chromosome marker, and the remaining nine are
autosomal. As this information already existed, genotypic
information from the nine autosomal loci were also used
in our analyses. The average number of alleles for these
loci is 17.9, and the average heterozygosity for the nine
markers is 81.1%.
Statistical Methods
Within each of the four case-control samples, we com-
puted x2 tests of Hardy-Weinberg equilibrium (HWE) in
the combined case and control sample for the 40 SNPs
and 9 STR markers. We computed a contingency x2 sta-
tistic comparing case and control allele frequencies for
each marker (Pritchard and Rosenberg 1999), grouping
STR alleles with !1% frequency in the four combined
samples. Under the null hypothesis that there are no
allele-frequency differences between the case and control
subjects, the statistic for each marker has a x2 distri-
bution with degrees of freedom equal to 1 less than the
number of alleles. Under the null hypothesis that the
populations have the same allele frequencies, the sum of
the statistics for all of the markers has a x2 distribution
with degrees of freedom equal to the sum of the degrees
of freedom from all of the markers. In effect, this statistic
tests for an overall difference in allele frequencies be-
tween the case and control subjects. We tested for strat-
ification, using the SNPs and STRs combined, and sep-
arately, as the marker types may differ in mutation rate
and history. Combining case and control subjects, we
tested for an overall difference in allele frequencies be-
tween the two U.S. white samples, between the combined
U.S. white samples (DM2 and HTN) and the Polish
DM2 sample, and between each of these samples and
the African American HTN sample, using the same con-
tingency x2 statistic used to test for stratification.
Association tests for PPARG.—We tested for associa-
tion between the PPARG SNP genotype or allele fre-
quencies and diabetes case/control status separately in the
Polish and U.S. samples, using a Pearson x2 statistic. We
computed the Mantel-Haenszel statistic and common es-
timate of the odds ratio (Mantel and Haenszel 1959) con-
trolling for sample in the combined U.S. and Polish sam-
ple. We used the Breslow-Day test (1994) to test for
homogeneity of the odds ratios in the two samples.
Population structure.—We used the computer pro-
gram structure (Pritchard et al. 2000a) to attempt to
identify clusters of genetically similar diploid individuals
frommultilocus genotypes.We did not define population
affinities when clustering individuals and used the cor-
related allele-frequency option to examine our Polish
and U.S. white samples for undetected structure thatmay
affect the PPARG association, using 34 SNPs and 9
STRs. We omitted one of our X-linked SNPs for these
analyses, as the two X-linked SNPs were closely linked
(∼30 kb) and in strong LD in our samples. To confirm
that the 34 SNPs and 9 STRs provided enough power
to identify distinct ethnic groups, we also ran structure
using the combined U.S. white and African American
HTN samples.
Results
HWE
We genotyped 40 SNPs in 3,472 individuals. For qual-
ity-control purposes, eight additional individuals were
repeatedly genotyped for each SNP: four individuals
were repeatedly genotyped 22 times, and four individ-
uals were repeatedly genotyped 20 times, for a total of
168 repeated genotypes per SNP. A reproducibility score
was constructed as the number of consistent genotypes
divided by the total number of attempted genotypes.
Low reproducibility can reflect either a high “no call”
rate (i.e., the software could not confidently call the ge-
notype) or a high genotyping-error rate. We eliminated
one SNP because of low (86%) reproducibility: for this
SNP, there were 20 “no calls” and three discordant ge-
notypes. The sample genotypes had a “no call” rate of
110% as well. All other SNPs had reproducibility scores
of 92%, and 33/40 had reproducibility 95%.
Four SNPs had extreme deviations from HWE (P !
), in which heterozygotes and only a single species.0001
of homozygote were observed in all of the samples, but
the allele frequency was high enough that a considerable
number of the other homozygote species had been ex-
pected. Neither the assay with low reproducibility score
nor the four assays with extreme HWE deviations had
significant allele or genotype frequency differences in any
of the four case-control samples. Further, the HWE test
P values for case and control subjects for each sample
were very similar. We therefore excluded these five assays
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Table 1
x2 Tests for Differences in Allele Frequency between Case and Control Subjects and for Allele Frequency between Selected Sample
Populations
POPULATION
VALUES FOR STR MARKERS
NO. OF
STRS
WITH
P ! .05
VALUES FOR SNP MARKERS
NO. OF
SNPS
WITH
P ! .05
P FOR
COMBINED
SNP AND
STRT df P T df P
Within samples:
Hypertension:
African American 53.1 72 .95 0 58.1 35 .01 3 .37
U.S. white 71.1 72 .51 0 40.9 35 .23 1 .35
Diabetes:
U.S. white 75.9 72 .35 0 24.4 35 .91 0 .66
Poland 78.3 72 .28 0 29.0 35 .75 1 .47
Between samples:
White/hypertension vs. white/diabetes 67.3 72 .63 0 35.1 35 .46 1 .61
U.S. white/diabetes vs. Polish/diabetes 193.4 72 135# 10 5 150.8 35 162# 10 13 !1020
White/hypertension vs. African
American/hypertension
1261.1 72 !1020 9 4002.6 35 !1020 30 !1020
from further analyses, leaving a total of 35 SNPs for
study of population stratification. We did not reject
HWE for the nine STR markers or the 35 SNPs in any
of the four samples.
Population Stratification
Table 1 shows the results of the population stratifi-
cation tests for the four samples and two sets of markers.
There is no evidence for stratification using the STR
markers or the combined STR and SNP markers. How-
ever, with the SNP markers alone, there is some evidence
( ) of stratification in the African American sam-Pp .01
ple. The large x2 value is due primarily to large differ-
ences in allele frequency between case and control sub-
jects at 3 SNPs, rather than smaller differences over all
35 SNPs. Our African American sample contains a het-
erogeneous mix of individuals. Some of these individuals
have parents or grandparents born outside of North
America (e.g., the Caribbean or Africa). For 79% of the
cases and 73% of the controls, we know with certainty
that the parents and all four grandparents were born in
North America. Among the case and control subjects in
this subgroup, there is no evidence for stratification
( for SNPs, for STRs).Pp .26 Pp .93
Between-Population Comparisons
The two U.S. white samples did not have significantly
different allele frequencies overall (table 1). The U.S.
white and U.S. African American HTN samples had sig-
nificantly different allele frequencies, as did the U.S. and
Polish white DM2 samples (table 1). For a small subset
( ) of the U.S. DM2 sample, all known parentsNp 46
and grandparents were born in central Europe. Neither
the SNP nor the STR frequencies were significantly dif-
ferent between this subset and the Polish DM2 sample
(SNPs: , df 35, ; STRs: , df2 2x p 32.8 Pp .58 x p 45.5
51, ; combined: , df 86, ).2Pp .69 x p 78.3 Pp .71
PPARG Test of Association
Genotyping rates of 96.2% and 92.6% were obtained
for the PPARg Pro12Ala polymorphism in the Polish
case and control subjects, and genotyping rates of 99.0%
and 99.2% were obtained for the U.S. case and control
subjects. HWE was not rejected in any of the subsamples
(HWE test statistic and for the PolishPp .40 Pp .25
case and control subjects, respectively; andPp .17
for the U.S. case and control subjects, respec-Pp .54
tively). In the Polish sample, there is strong evidence for
an association between case status and genotype (Pear-
son , df 2, ) (table 2), and case2x p 16.04 Pp .0003
status and allele frequency ( , df 1,2x p 16.37 Pp
) (table 2). The odds ratio for the C allele in55# 10
cases versus controls is 0.60 (95% CI 0.47–0.77). In the
U.S. sample, no such association is evident for genotype
( , df 2, ) (table 2), or allele frequency2x p 0.70 Pp 0.71
( , df 1, ) (table 2). The odds ratio for2x p 0.19 Pp .66
the C allele in this sample is 0.94 (95% CI 0.70–1.26).
The odds ratios in the two samples are significantly dif-
ferent ( , df 1, ). The Mantel-Haenszel2x p 5.14 Pp .02
estimate of the common odds ratio and CI for the two
samples combined is 0.72 (95% CI 0.60–0.87), which
is very similar to the common odds ratio and CI cal-
culated in a recent meta-analysis (Altshuler et al. 2000).
Analysis of Structure
Genetic differentiation within the two DM2 popula-
tions was low, and Fst values for individual loci were not
greater for the U.S. population than for Poland, ranging
from 0.0009 to 0.0752 for both populations. To detect
the presence of cryptic population structure, we used the
program structure (Pritchard et al. 2000a). This program
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Table 2
Genotypes and Allele Frequencies for the PPARg Pro12Ala Polymorphism in the Polish and
U.S. DM2 Samples, Odds Ratios and 95% CIs for C Allele in Cases, and P Values of
Association Tests
POPULATION
AND
SUBJECTS
NO. OF SUBJECTS WITH
GENOTYPE
ALLELE
FREQUENCIES
ODDS
RATIO 95% CI PaCC GC GG Total C G
Poland: .60 .47–.77 .00005
Case 8 108 365 481 .129 .871
Control 22 139 302 463 .198 .802
U.S. .94 .70–1.26 .66
Case 2 92 401 495 .097 .903
Control 4 94 398 496 .103 .897
Combined .72 .60–.87 .0007
a P values are for differences in allele frequency; combined-sample P value is the Mantel-
Haenszel test controlling for sample.
attempts to identify subpopulations by grouping indi-
viduals in a way that minimizes Hardy-Weinberg and
linkage disequilibrium among unlinked markers. A sin-
gle population fit both the U.S. and Polish sample data
best, as well as the combined U.S./Polish sample. Al-
though our U.S. and Polish DM2 samples have statis-
tically significantly different allele frequencies, the actual
differences in allele frequencies are relatively small
(range 0.03–0.06 for the 13 SNPs with differences sig-
nificant at the 0.05 level). Thus, the combined U.S. and
Polish sample exhibits neither more Hardy-Weinberg
disequilibrium within markers than expected nor more
LD between unlinked markers than expected, and struc-
ture is unable to identify subpopulations. Much larger
sample sizes would be required to detect Hardy-Wein-
berg disequilibrium and/or linkage disequilibrium under
these conditions. In contrast, structure easily identified
the white and African American subgroups of our com-
bined hypertension samples (analyses not shown).
Discussion
In the four case-control collections we examined, we
found no evidence for significant cryptic population struc-
ture for any of the marker sets within any of the three
white samples. With the combination of 35 SNPs and 9
STRmarkers, we should have high power to detect strong
stratification in these samples if it exists (Pritchard and
Rosenberg 1999). Thus, it is unlikely that there is strong
hidden structure in these particular samples. Some low-
level structure may nevertheless be present in the popu-
lations from which these samples were drawn, and, more-
over, the prevalence of DM2 and HTN is known to vary
substantially across populations, even within Europe (see,
e.g., Van Den Hoogen et al. 2000; World Health Organ-
ization Web site), but the fact that we do not detect any
stratification in three of the four independent case-control
samples selected here is very encouraging.
One exception to this was the African American sam-
ple for which the SNP markers, although not the STR
markers, did show evidence for stratification in the case
subjects versus the control subjects (table 1). The African
American population currently residing in the United
States is known to be admixed, primarily with whites,
and several studies have examined the extent of admix-
ture in populations from different U.S. regions. These
studies reveal a complex situation with levels of admix-
ture differing throughout the United States and the Car-
ibbean (Chakraborty et al. 1992; Parra et al. 1998; Des-
tro-Bisol et al. 1999). In this sample, we therefore used
more-extensive demographic information (ethnicity in-
formation for three generations). We did not initially use
any of the information available on birthplace for indi-
viduals or their parents and grandparents. On examining
birthplace information, however, we found that the Af-
rican American sample contained recent Caribbean and
African immigrants, in addition to third-generation
North Americans. The simplest approach to this sample
was to remove all the known recent immigrants from
both the case and control subjects, leaving ∼79% of the
case subjects and ∼73% of the control subjects for whom
all three generations were born in North America. Al-
though varying and unknown degrees of finer-level struc-
ture must remain in this sample, there was no evidence
for population structure in either the SNPs or STRs
within this subgroup after taking thismeasure, suggesting
that careful matching using demographic parameters,
such as region of U.S. residence and recency of immi-
gration, may help to reduce stratification bias in African
Americans to nominal levels, at least formoderate sample
sizes. Nevertheless, because the extent of bias caused by
population structure will increase with sample size (Prit-
chard and Donnelly 2001), which provides greater power
to detect both real associations and any weak spurious
associations, it may be imperative to type additional
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markers in larger studies so that such finer-level structure
can be detected.
Our ability to detect population structure when it is
present is demonstrated in this African American case-
control sample (table 1) and also by the comparisons
between populations (table 1). The latter represent an
artificially extreme example of stratification, in which
one group comprises members of a single “self-defined
ethnicity” and the comparison group comprises mem-
bers of another. Our comparisons between these sam-
ples indicate the ability to detect deliberate structure,
with both sets of markers showing very significant dif-
ferences between groups when the U.S. whites are com-
pared with the African American sample (table 1). The
comparison between the two separate U.S. white sam-
ples shows no significant difference in allele frequencies.
In contrast, the comparison between the U.S. white
DM2 and the Polish DM2 populations clearly indicates
that these populations have significantly different allele
frequencies. A comparison of birth locations over three
generations revealed that both samples have some het-
erogeneity in their origins. However, the Polish group,
which was collected from a single site in southern Po-
land, is considerably more homogeneous. Of the Polish
sample, 74.5% are Polish by birth, with Polish-born
parents and/or grandparents. An additional 8.8% have
at least one Polish-born parent. The remaining 16.7%
are primarily Central and Eastern European in origin.
In contrast, the sample of U.S. whites with DM2 is
composed of individuals for whom the two previous
generations were born in the U.S. (46%) and numerous
first- and second-generation immigrants from through-
out Europe. Distribution of birth country among index
cases, parents, and grandparents not born in the United
States is similar in case and control subjects. However,
more than twice as many control subjects were born
outside of the United States than case subjects (12.2%
vs. 4.6%). The differences in allele frequency between
these two populations may thus reflect the greater het-
erogeneity and more-diverse European origins of the
U.S. sample.
In addition to the ability to assess population struc-
ture within a case-control sample, the key question of
interest is whether such stratification can contribute sig-
nificantly to association—specifically, to reported pos-
itive associations. The only association we had typed at
the time of assessing stratification in these four samples
was the common Pro12Ala allele of PPARg in the two
DM2 case-control samples (Poland and the U.S. whites),
in which the proline allele has been reproducibly, al-
though variably, associated with cases and with an in-
creased risk of DM2 (Altshuler et al. 2000). In our two
populations, we were able to replicate this strong as-
sociation in the Polish sample, whereas, in the U.S. sam-
ple, we found no evidence for an association. Despite
this difference, comparison of the estimated risk in each
of these two populations with the meta-analysis of Al-
tshuler and colleagues (2000) demonstrates that both
are individually consistent with the earlier studies and
with the modest effect previously described. A sample
size insufficient for reliable detection of the association
has been suggested to be one key factor in the variability
in prior studies (Altshuler et al. 2000), and here too we
find that the combined population of 1,000 case subjects
and 1,000 control subjects gives stronger support for
the association and is closer to the modest across-pop-
ulation effect demonstrated in the meta-analysis in that
study (table 2).
Although it is unlikely that the positive association
observed here in the Polish population is the result of
hidden substructure, a reason we may have failed to
detect an association in the U.S. sample could be that
subtle stratification or population heterogeneity masks
the effect in this sample. Recent studies have shown that,
by use of high-resolution statistical methods such as
those in structure (Pritchard et al. 2000a, 2000b), on
multilocus genotypes, it is practical to distinguish re-
lated populations of recent common ancestry (Rosen-
berg et al. 2001). Rosenberg et al. (2001) were able to
distinguish a distinct genetic signature in a Libyan Jew-
ish population, although the population had likely been
relatively secluded from the others tested. Here, despite
a comparable number of markers, we were unable to
detect genetically distinguishable subpopulationswithin
either DM2 case-control sample. This may not be sur-
prising, given the likely continued mixing of European
white populations. Recent recommendations suggest
that structure may require hundreds of markers to re-
liably identify very closely related subpopulations and
populations with a high degree of admixture (Pritchard
et al. 2000a, 2000b; Wilson et al. 2001; Pritchard and
Donnelly 2001). It is important to distinguish between
heterogeneity and structure within a case-control sam-
ple. As long as the heterogeneity is equivalent in case
and control subjects (i.e., the two groups have the same
mix of ethnic/genetic subgroups), stratification bias will
not occur. Nevertheless, it could occur in repeated sam-
plings from the same population if the underlying het-
erogeneity in each sampling is not well matched with
the others. Moreover, stratification bias will decrease
with an increasing number of subpopulations, since bi-
ases will tend to cancel each other out (Wacholder et
al. 2000). As far as can be determined, given the dem-
ographic data, the country-of-ancestry distribution is
similar in the U.S. DM2 case subjects and control sub-
jects, although the control subjects tend to be more re-
cent immigrants than the case subjects. Thus, if popu-
lation structure or heterogeneity remains in one sample
here, it will require many more markers to detect it and
thus correct for it.
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Figure 1 Power to detect an allelic association for 500 case
subjects and 500 control subjects under a multiplicative genetic model
with genotypic risk ratio 1.25, by risk-allele frequency and disease
prevalence. Allele frequencies for case and control subjects were de-
termined under the given genetic models; power to detect the difference
in allele frequencies was calculated for the exact test for a 2 # 2
contingency table, by the method of Walters (1979).
These two diabetes populations exemplify the diffi-
culties in reproducibly detecting risk factors of modest
effect in case-control studies, where significant between-
study heterogeneity in findings is frequent and the re-
sults of an initial study may correlate only modestly
with subsequent studies of the same association (Edi-
torial 1999; Altshuler et al. 2000; Ioannidis 2001). Al-
though replication has become an accepted standard,
variation in the strength of an association is common,
even between studies of seemingly similar populations,
such as the two presented here. Both populations are
European in origin, cases were ascertained identically
in the two populations, case and control subjects were
matched with the same parameters in both, the two
samples are equal in size, and neither had detectable
population stratification, yet the results of an allelic as-
sociation differ between the two. Small sample size is
one predictor of study discrepancy (Ioannidis 2001),
and our combined sample clearly gives a more accurate
estimate of the population effect of the allele, suggesting
that sample size is a factor. Additionally, a gene effect
may be genuinely stronger in one subpopulation than
in another. The ability to access large sample numbers
and to share data for meta-analyses may be key to
proper assessment of the validity of an association.
One issue that has not been rigorously addressed in
the context of study replication is the variation in (pu-
tative) risk-allele frequencies across replication samples.
Even when the genetic effect of a variant and the disease
frequency are the same for two populations, samples of
the same size from these two populations can have dras-
tically different power to detect the association, de-
pending on the frequency of the risk allele. For example,
the allele frequency of the proline risk allele for PPARg
is ∼0.90 in the U.S. population and ∼0.80 in the Polish
population from which we sampled. For a genotype
relative risk of 1.25 and a multiplicative model (Altshul-
er et al. 2000), the Polish 500 case, 500 control sample
has 70% greater power than the U.S. sample (51% vs.
30% power) to detect an effect. Larger sample sizes
make a difference: for 1,000 case subjects and 1,000
control subjects, the power of the Polish sample would
be only 47% greater than the U.S. sample (81% vs.
55% power). Figure 1 illustrates that for the combi-
nation of (1) a weak genotypic risk ratio and (2) high
(10.80) or low (!0.20) risk-allele frequencies, small
changes in risk-allele frequencies have large effects on
power. The effect is much greater in magnitude than the
effect of disease prevalence in a population. Thus, dif-
fering risk-allele frequencies across populations, result-
ing in drastic differences in power, are one more factor
contributing to the difficulty in replicating association
studies for complex phenotypes.
Our data show that, if matching is done carefully, using
a reasonable amount of demographic data, then unan-
ticipated genetic stratification can be kept to a minimum,
at least for studies of similar size to our four examples
here. Whether our results can be generalized to larger
sample sizes depends on the unknown extent of remain-
ing undetected structure. Clearly, investigators should
confirm that new associations are not due to stratifica-
tion, using appropriate methods. Our results should,
however, be encouraging to investigators who have care-
fully matched their case and control subjects. Isolated
populations are a popular target for association studies
(Peltonen at al. 2001), because their homogeneity mini-
mizes population structure, yet they may not always be
appropriate for the disease or sample number of interest,
and our results are encouraging for studies in more het-
erogeneous populations. Perhaps just as important in as-
sociation-study design, however, are other causes of non-
replication in case-control studies. These may include
different clinical definitions or different phenotypes being
compared, different environmental and genetic back-
grounds that should also be controlled for as carefully
as possible, and differences in the power to detect an
association.
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